杏彩彩票手机app下载

科学研究

科研动态

2011年

时间:2018年04月18日 访问次数:
1、Wu JZ, Li JL, Cai YP, Pan Y, Ye FQ, Zhang YL, Zhao YJ, Yang SL, Li XK, Liang G* : Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-Inflammatory Agents. Journal of Medicinal Chemistry. 2011, 54(23): 8110-8123. (IF=5.447) 
2、Wang Y, Yu CC, Pan Y, Li JL, Zhang YL, Ye FQ, Yang SL, Zhang H, Li XK, Liang G*: A Novel Compound C12 Inhibits Inflammatory Cytokine Production and Protects from Inflammatory Injury In Vivo. Plos One. 2011, 6(9): e24377. (IF=3.234) 
3、Zhao YZ, Sun CZ, Lu CT*, Dai DD, Lv HF, Wu Y, Wan CW, Chen LJ, Lin M, Li XK: Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro. Cancer Letters. 2011, 311(2): 187-194. (IF=5.621)
4、Tang LJ, Chen X, Sun YN, Ye J, Lu J, Han Y, Jiang X, Cheng CC, He CC, Qiu PH*, Li XK: Synthesis and biological studies of 4',7, 8- trihydroxy- isoflavone metal complexes. Journal of Inorganic Biochemistry. 2011, 105(12): 1623-1629. (IF=3.444) 
5、Xie LY*, Song CY, Lou YY, Xu Z, Zhang ML, Dong BJ, Gao HC, Li XK: Studies on Metabolic Characteristics and Pathological Mechanisms of Diabetic Ulcers by 1H NMR-based Metabonomics. Acta chimica sinica. 2011, 69(19): 2265-2271. (IF=1.426) 
6、Xie LY, Zhang ML, Dong BJ, Guan MM, Lu MF, Huang ZF, Gao HC*, Li XK: Improved refractory wound healing with administration of acidic fibroblast growth factor in diabetic rats. Diabetes research and clinical practice. 2011, 93(3): 396-403. ( IF=2.538)
7、Zhao YZ, Xu YY, Li X, Lu CT*, Zhang L, Dai DD, Sun CZ, Lv HF, Li XK, Yang W: An In Vivo Experiment to Improve Pulmonary Absorption of Insulin Using Microbubbles. Diabetes Technology & Therapeutics. 2011, 13(10): 1013-1021. (IF=2.106) 
8、Huang ZF, Lu MF, Zhu GH, Gao HC, Xie LY, Zhang XQ, Ye CH, Wang Y, Sun CC, Li XK*: Acceleration of diabetic-wound healing with PEGylated rhaFGF in healing-impaired streptozocin diabetic rats. Wound repair and regeneration. 2011, 19(5): 633-644. (IF=2.745)
9、Xiang Q, Xiao J, Zhang HB, Zhang X, Lu MF, Zhang H, Su ZJ, Zhao W, Lin C, Huang YD*, Li XK: Preparation and characterisation of bFGF-encapsulated liposomes and evaluation of wound-healing activities in the rat. Burns. 2011, 37(5): 886-895. (IF=1.88)
10、Lu CT, Zhao YZ*, Tian XQ, Li WF, Huang PT, Li XK, Sun CZ, Zhang L: Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer chemotherapy and pharmacology. 2011, 68(2): 343-348. (IF=2.769)
11、Lin ZF, Gong Q, Zhou ZH, Zhang WX, Liao SX, Liu YL, Yan XX, Pan XB, Lin SQ, Li XK*: Increased plasma CXCL16 levels in patients with chronic kidney diseases. European journal of clinical investigation. 2011, 41(8): 836-845. (IF=2.734)
12、Yang JL, Tan Y, Zhao FL, Ma ZS, Wang YH, Zheng SR, Epstein PN, Yu J, Yin X, Zheng Y, Li XK, Miao LN, Cai L*: Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage. American journal of physiology-endocrinology and metabolism. 2011, 301(1): E132-E144. (IF=3.785)
13、Xu YY, Lu CT, Fu HX, Zhao YZ*, Yang W, Li X, Zhang L, Li XK, Zhang M: Comparing the Enhancement Efficiency Between Liposomes and Microbubbles for Insulin Pulmonary Absorption. Diabetes Technology & Therapeutics. 2011, 13(7): 759-765. (IF=2.106)
14、Wang Y, Xiao J, Zhou HP, Yang SL,Wu XP, Jiang CX, Zhao YJ, Liang DL, Li XK, Liang G*: A Novel Monocarbonyl Analogue of Curcumin, (1E,4E)-1,5- Endoplasmic Reticulum Stress Signaling Pathway. Journal of medicinal chemistry. 2011, 54(11): 3768-3778. (IF=5.447)
15、Huang ZF*, Wang HY, Lu MF, Sun CC, Wu XP, Tan Y, Ye CH, Zhu GH, Wang XJ, Cai L, Li XK: A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol. Plos one. 2011, 6(6): e20669. (IF=3.234) 
16、Tian HS, Tang L, Wang Y, Wang XJ, Guan LL, Zhang J, Wu XP, Li XK*: Lactose Induction Increases Production of Recombinant Keratinocyte Growth Factor-2 in Escherichia coli. International Journal of peptide research and therapeutics. 2011, 17(2): 123-129. (IF=0.905) 
17、Zhao BH, Lian QQ, Chu YH, Hardy DO, Li XK, Ge RS*: The inhibition of human and rat 11 beta-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances. Journal of steroid biochemistry and molecular biology. 2011, 125(1-2): 143-147. (IF=3.628)
18、Lin ZF*, Zhou ZH, Liu YL, Gong Q,Yan XX, Xiao J, Wang XJ, Lin SQ, Feng WK, Li XK: Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese. Plos one. 2011, 6(4): e18398. (IF=3.234)
19、Guo CS, Sun Y, Zhou B, Adam RM., Li XK, Pu WT., Morrow BE., Moon A, Li X*: A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis. Journal of clinical investigation. 2011, 121(4): 1585-1595. (IF=13.215)
20、Wu XP*, Jia XL, Ji YH, Wang C, Yu YL, Gao SS, Li QC, Li XK: Effects of a Synthetic bFGF Antagonist Peptide on the Proteome of 3T3 Cells Stimulated with bFGF. International journal of peptide research and therapeutics. 2011, 17(1): 53-59. (IF=0.905)
21、Zhang C, Jin SZ, Guo WY, Li C, Li XK, Rane MJ, Wang GJ, Cai L*: Attenuation of Diabetes-Induced Cardiac Inflammation and Pathological Remodeling by Low-Dose Radiation. Radiation research. 2011, 175(3): 307-321. (IF=2.911)
22、Li HY, Dong YY, Sun YP, Zhu Erle, Yang J, Liu XM, Xue P, Xiao YS, Yang SL, Wu JY, Li XK*: Investigation of the microRNAs in safflower seed, leaf, and petal by high-throughput sequencing. Planta. 2011, 233(3): 611-619. (IF=3.263)
23、Lin L*, Cai YP, Lin RP, Yu Li, Song CY, Gao HC, Li XK: New integrated in vivo microdialysis-electrochemical device for determination of the neurotransmitter dopamine in rat striatum of freely moving rats. Microchimica acta. 2011, 172(1): 217-223. (IF=3.741)
24、Tan Y, Ichikawa T, Li JQ, Si QS, Yang HT, Chen XB, Goldblatt CS., Meyer CJ, Li XK, Cai L, Cui TX*: Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo. Diabetes. 2011, 60(2): 625-633. (IF=8.095)
25、Zhao YZ*, Lu CT, Zhou ZC, Jin Z, Zhang L,Sun CZ, Xu YY, Gao HS, Tian JL, Gao FH, Tang QQ, Li W, Xiang Q, Li XK, Li WF: Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment. Journal of drug targeting. 2011, 19(2): 154-160. (IF=2.741)
26、Li HY, Dong YY, Yin HL, Wang N, Yang J, Liu XM, Wang YF, Wu JY*and Li XK*: Characterization of the stress associated microRNAs in Glycine max by deep sequencing. BMC Plant Biol. 2011, 11: 170. (IF=3.813)
27、Fu HQ, Pang SF, Xue P, Yang J, Liu XM, Wang YF, Li TT, Li HY, Li XK*: High Levels of Expression of Fibroblast Growth Factor 21 in Transgenic Tobacco (Nicotiana benthamiana). Applied Biochemistry and Biotechnology. 2011, 165(2): 465-475. (IF=1.735)